Clinical Trial 40232

Long Beach, CA 90806


Summary:

An Open-label, 8-Week Study of Safety and Efficacy of Pimavanserin
Treatment in Adults With Parkinson’s Disease and Depression


Qualified Participants Must:

• Patient is a male or female 50 years of age or older
• Has a clinical diagnosis of idiopathic Parkinson's disease with a minimum duration of 1 year


Qualified Participants May Receive:

Compensation for time and travel 


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.